ArticleThe Korean journal of pain2026
Analgesic effect of intraoperative sufentanil on postoperative pain in patients undergoing robot-assisted urologic surgery: a retrospective propensity score-matched analysis.
Article in The Korean journal of pain, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Robot-assisted urologic surgery is associated with reduced intraoperative bleeding and shortened hospital stays; however, postoperative pain remains concerning. Thus, the authors investigated whether intraoperative sufentanil is more effective than remifentanil in reducing postoperative pain and analgesic consumption. Methods: Patients undergoing robot-assisted urologic surgery (March 2023 to March 2024) were divided into the sufentanil or remifentanil groups and matched by propensity score. The primary outcome was the distribution of pain severity after surgery. Secondary outcomes included pain scores and rescue analgesic consumption. Results: Among 832 eligible patients, 194 were matched from each group. The distribution of pain severity after surgery was significantly different between groups (rank-biserial correlation -0.34, 95% confidence interval [CI] -0.43 to -0.24; Conclusions: Intraoperative sufentanil was associated with lower postoperative pain and analgesic consumption than was remifentanil in patients undergoing robot-assisted urologic surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.